Celtec is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early discovery to product development. We focus on developing novel therapeutic products that harness a patient’s own immune system to target and kill cancer cells.
Celtec has two core technologies including fully-human scFv system and universal linker platform for next generation of cellular immunotherapies.
Those novel strategies of immune cell therapy have the potential to be more effective and less long-term side effects regardless of the type of current treatments. Moreover, Celtec provides a universal, cost-effective, and easy process cutting-edge technology for cancer therapy.